Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0BCP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,764
Award facts
- Contract value 100% obligated
- $38,763.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $38,763.64 delivery order to AmerisourceBergen Drug Corp on April 16, 2026, for Rinvoq ER 30 mg tablets (pharmaceutical product 4571513981).
Place of performance is Conshohocken, PA. Ultimate completion date is April 17, 2026. The order carries firm fixed-price pricing with no set-aside.
Quick answers
Who was awarded contract SPE2DR26F0BCP?
SPE2DR26F0BCP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 16, 2026.
How much is contract SPE2DR26F0BCP worth?
The government has obligated $38,764 on SPE2DR26F0BCP.
Is contract SPE2DR26F0BCP an order under another contract?
Yes. SPE2DR26F0BCP is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F0BCP competed?
The extent of competition for SPE2DR26F0BCP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award